Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

153.57 -2.05 (-1.31%)
Streaming Delayed Price Updated: 9:35 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Masimo Named One of Fast Company’s Most Innovative Companies in North America
From Masimo
Via Business Wire
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco
Apple has been considering incorporating anemometers, bolometers, heat flux sensors, solar radiation sensors, thermometers, and water sensors into future iterations of the Apple Watch. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
From Masimo
Via Business Wire
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
From Masimo Corporation
Via Business Wire
Recap: Masimo Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
From Masimo Corporation
Via Business Wire
A Preview Of Masimo's Earnings
Via Benzinga
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
From Masimo
Via Business Wire
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
From Masimo
Via Business Wire
Apple's Win
We've also got some productivity tips for the new year. 
Via The Motley Fool
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
From Masimo
Via Business Wire
Tim Cook Opens Up On Apple Watch Ban, Licensing Masimo' Tech: 'We're Focused On Appeal'
Apple CEO Tim Cook has confirmed the company's plan to appeal the ban on its Apple Watch imposed in a patent dispute with Masimo, stating they have no intention of settling and will focus on the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
What Wall Street Experts Are Saying About Apple Ahead Of Earnings
Bulls and bears divided on Apple ahead of 'likely not great' report. 
Via Talk Markets
Vision Pro Exceeds Expectations, Banned Apple Watch Feature Saves Teen And More: Top News In Appleverse This Week
From booking a majority of TSMC's initial 2nm chips capacity to rolling out an "Alternative App Store" model in the EU, Apple's moves were far-reaching. 
Via Benzinga
Tim Cook Says 'Thanks' After Banned Apple Watch Feature Saves Teen From Altitude Sickness
A teenager suffering from altitude sickness in Peru was saved using the blood oxygen detection feature on an Apple Watch, a function currently banned in the U.S. due to a patent dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Samsung To Reportedly Level Up Its Health Tech Game — Plans To Challenge Apple With Noninvasive Blood Sugar Monitoring
Samsung Electronics is stepping up its health tech game by developing noninvasive glucose and continuous blood pressure monitoring technology, challenging Apple and other tech giants in the health-care... 
Via Benzinga
Apple's Move To Remove Blood Oxygen Feature In US Watches May Affect Sleep Apnea Detection, Says Mark Gurman
Apple's removal of the blood oxygen tracking feature from its smartwatches could impact its future health-related capabilities, including sleep apnea detection, as highlighted by Mark Gurman. 
Via Benzinga
Apple Watch Sidesteps Looming Ban, Cupertino Giant Outshines Samsung In Sales, Tim Cook Shows BTS Of Vision Pro: This Week In Appleverse
From securing the pole position in global smartphone shipments to navigating tricky patent disputes, Apple was in the thick of news this week 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo CEO 'Wholeheartedly' Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature
"Pulse oximetry is not useful unless it is a continuous monitor. That happens during sleep," Kiani explained. 
Via Benzinga
Apple Watch Versions Minus Blood Oxygen Feature To Go On Sale In US As Cupertino Devises Way To Sidestep Looming Ban
Apple Inc. modifies its latest Apple Watch models for the U.S. market by removing the blood oxygen feature, in response to a pending ban due to an intellectual property dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
From Masimo
Via Business Wire
Bob Chapek Goes From Disney To Battling Apple: Inside New Role Announced For Former Media Executive
Bob Chapek is moving from Disney to healthcare company Masimo. Chapek's new company is working through patent litigation against Apple. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Courts Reinstate Ban On Apple Watches With Blood Oxygen Sensors
A federal appeals court on Wednesday shut down Apple's attempt to allow U.S. imports of Apple Watches with blood-oxygen sensors while it appeals a ban on the products. 
Via Benzinga
Masimo Announces New Member of the Board of Directors
From Masimo
Via Business Wire
Apple Dodges Import Ban In Apple Watch Patent Battle With Masimo
Apple potentially avoids import ban for Apple Watch models in patent dispute with Masimo, with software redesign to remove blood-oxygen feature. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
ITC Wants Apple Ban Reinstated, Calls Apple's Arguments 'Weak And Unconvincing'
The U.S. International Trade Commission (ITC) has opposed Apple's plea to put on hold an import ban on certain Apple Watch models. 
Via Benzinga
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
From Masimo Corporation
Via Business Wire
Apple Stock Is Still A Buy. Here’s Why.
Investors should remain bullish on AAPL stock as the company grows its services business and brings new products to market. 
Via InvestorPlace
There's Uncertainty Around Apple's Patent Appeal For Watch, Masimo's Royalty Exposure Is Priced In - Analyst Downgrades
Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.